Sulfagenix
Chesterland, US · Founded 2011 · Delaware corporation
Sulfagenix develops SG1002, an oral hydrogen sulfide prodrug designed to treat oxidative stress-related diseases including cardiovascular disorders, cancer, and other chronic conditions. The company targets patients with conditions ranging from heart failure to cancer, diabetes, and neurodegeneration.
Founders & leadership
Sulfagenix was founded in 2011 by Gabriel Gojon-Romanillos and Gabriel Gojon-Zorrilla.
GG
Gabriel Gojon-RomanillosCo-founder
GG
Gabriel Gojon-ZorrillaCo-founder, Head of R&D
CP
Carlos PalmainCEO
DG
Dr. Guillermo A. MoralesCOO & Scientific Advisory Board Coordinator
AT
Anthony T. GiordanoFormer President and CEO
Board
GG
Gabriel Gojon, Jr.Board director
CV
Cesar VidalesChairman
Reported raises · per SEC filings
Form D private placements$2.6M disclosed across 2 rounds · 2014
▶$1.3MraisedDec 2016 · 2 investors · BiotechnologyRule 506(b)
▶$1.3MraisedDec 2016 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Anthony GiordanoExecutive Officer, Director
- Gabriel Gojon, Jr.Director
- Cesar VidalesDirector
- Offering amount
- $1.6M
- Amount sold
- $1.3M
- Minimum investment
- $10K
- First sale
- Nov 2014
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
▶$1.3MraisedMar 2014 · 2 investors · PharmaceuticalsRule 506(b)
▶$1.3MraisedMar 2014 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Gabriel Gojon, Jr.Director
- Anthony GiordanoExecutive Officer, Director
- Cesar VidalesDirector
- Offering amount
- $3M
- Amount sold
- $1.3M
- Minimum investment
- $100K
- First sale
- Jan 2014
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Sulfagenix do?
- Sulfagenix develops SG1002, an oral hydrogen sulfide prodrug designed to treat oxidative stress-related diseases including cardiovascular disorders, cancer, and other chronic conditions. The company targets patients with conditions ranging from heart failure to cancer, diabetes, and neurodegeneration.
- Who founded Sulfagenix?
- Sulfagenix was founded by Gabriel Gojon-Romanillos, Gabriel Gojon-Zorrilla in 2011.
- How much funding has Sulfagenix raised?
- Sulfagenix has disclosed $2.6M raised across 2 rounds.
- Where is Sulfagenix headquartered?
- Sulfagenix is headquartered in Chesterland, US.